Our news

THM Capital Advisory supports Plasana Medical in raising €4 million to accelerate the development of Plasana One®, a cold plasma device for chronic wounds.

Plasana Medical, a medtech created by the Plasma Physics Laboratory at École Polytechnique and CNRS and created by the TechnoFounders startup studio, announces a 4 million euros equity round, supplemented by non-dilutive funding (grants and bank loans).

This operation brings together TF Participations (funds managed by TechnoFounders), as well as several family offices and business angels.

Plasana Medical is developing Plasana One®, an innovative medical device to treat chronic wounds, including diabetic foot ulcers, venous leg ulcers, and bedsores.

Thanks to its proprietary multi-jet cold plasma technology, Plasana One® aims to accelerate healing by 30 to 50% while reducing the risk of infection.

The device is also distinguished by a treatment speed announced as significantly higher (6 to 12 times faster), a painless approach, and an adapted use at home, where the majority of patients are cared for.

The funds raised will finance the PLASANA GENESIS clinical trial currently underway, with the aim of obtaining the CE mark in 2026, preparing for marketing in Europe and launching the regulatory process in the United States.

Yves Matton (École Polytechnique), co-founder of TechnoFounders ten years ago and at the initiative of several deeptech projects including Plasana Medical, was appointed CEO of the company in May.

THM Capital Advisory acted as financial advisor to Plasana Medical, with a team composed of Thomas Mitard, Aurélien Prost and Ali Koçak.

THM Capital Advisory advised the shareholders of Caerus Medical in connection with the sale of the company to Gleamer, an international player in artificial intelligence applied to radiology.

This transaction is part of Gleamer's strategy to strengthen its position as a key innovator in medical imaging, by expanding its technological scope towards MRI.

Gleamer has acquired Caerus Medical, a pioneer company specializing in AI solutions dedicated to the diagnosis of lumbar spine pathologies using MRI.

Thanks to this acquisition, Gleamer extends its existing expertise in radiography, CT and breast imaging to magnetic resonance imaging, in order to consolidate its AI-assisted medical imaging offer.

The Caerus Medical solution was developed in three years by David Vittecoq, CEO and minority shareholder, with the financial and operational support of its majority strategic shareholder, France Imageries Territories, a French reference group in imaging.

Caerus Medical has designed advanced software that automates and improves the diagnosis of lumbar disorders based on MRIs, offering radiologists greater precision and efficiency.

Shareholders selected Gleamer as a strategic partner to support the acceleration of Caerus Medical's business growth.

As part of the transaction, David Vittecoq will continue to lead Caerus Medical, translating his confidence in the group's vision and in the potential of AI to shape the future of radiology.

This transaction is among the first external growth transactions carried out by Gleamer and is an important step in the construction of an AI-assisted diagnostics platform covering a wide range of pathologies.

THM Capital Advisory advised the sellers in the capacity of financial advisor (Thomas Mitard, Aurélien Prost, Adam Ouahid).

THM Capital Advisory advised the shareholder of the Saint-Claude Medical Imaging Center (IMSC) in connection with the sale of the structure to the IMDEV group.

Located in Saint-Quentin (Aisne), the center operates 4 heavy imaging equipment and also provides the radiology service for the Saint-Claude Private Hospital clinic (ELSAN group), in addition to a city office.

A few days before the sale, the Hauts-de-France Regional Health Authority issued a new authorization for additional sectional imaging equipment, offering IMSC an additional growth driver.

This dynamic is part of a context where the needs for access to imagery and continuity of care are major challenges for territories.

Approaching his sixties, the sole shareholder radiologist wanted to prepare for his retirement and organize the transfer, in the best conditions, of a structure developed over more than 25 years.

He called on THM Capital Advisory to assist him in identifying potential buyers and in negotiating the terms of the transaction.

The choice of the transferor fell on the IMDEV group, presented as one of the leaders in medical imaging in France (120 centers, more than 130 associated doctors and 800,000 annual examinations).

As part of the operation, the radiologist will continue his activity for 5 years in order to ensure continuity of care for the center's patients, and has decided to reinvest significantly in IMDEV's capital, testifying to the trust established with the group's managers.

THM Capital Advisory advised the transferor as financial advisor (Thomas Mitard, Aurélien Prost), alongside Lawderis (Bertrand Araud, Yann Fouquet-Michel) as legal and tax advisor.

WeKare announces the raising of 2 million euros as part of its second financing round, with the support of THM Capital Advisory as financial advisor.

This operation, carried out with private investors including a group of around fifteen lead investors gathered within CWM, should enable WeKare to accelerate its development after a first financing round of 1 million euros in 2022.

WeKare is a French start-up that offers liberal health professionals — doctors, paramedics and alternative medicine practitioners — the opportunity to rent turnkey medical practices in a flexible manner, starting from one day per week.

The offer also includes services contracted with providers (appointment scheduling, administrative tasks, accounting, training, etc.), in order to free up medical time and allow practitioners to focus on their patients.

Co-founded by Robin Gauter and Nicolas Maciocia, WeKare was born from a field observation: many liberal professionals struggle to find premises adapted to their real uses, in particular to work part-time, start their business, unload ancillary tasks and break isolation.

The company offers offices in perfect condition, equipped and decorated, as well as living spaces that promote sharing within a community of practitioners, while ensuring the upkeep and maintenance of the premises.

WeKare already operates around thirty offices in 5 centers in Paris, with an occupancy rate greater than 90%.

With this funding, WeKare plans to duplicate its model and accelerate its deployment in Paris and in the regions, with an ambition to open more than 800 firms within 5 years.

THM Capital Advisory supported the managers of WeKare as financial advisor (Thomas Mitard, Aurélien Prost), alongside Klyde Avocats (Matthieu Giboire, Ada Costantini) as legal advisor.

CWM (Frédéric Ruppli) acted as financial advisor to lead investors, accompanied by Piotrait Giné Avocats (François Giné) as legal advisor.

Advanced Life Solutions announces the raising of the second installment of its Series A, worth 2.5 million euros, in order to accelerate its development in Europe, the United States and the Middle East.

This operation is carried out with the support of THM Capital Advisory, the company's financial advisor.

Founded by Silvina Ramella, an internationally renowned scientist in organ transplantation and former CEO at one of the main European companies in the sector, Advanced Life Solutions is developing Perla®, a new liquid designed to preserve and protect grafts.

The aim of the solution is to improve the functional recovery of transplanted organs and to increase their lifespan.

Perla® responds to the structural evolution of transplants: the proportion of more fragile grafts, especially from older donors, is increasing. However, the preservation fluids used routinely in transplant services are based on formulations designed 30 to 40 years ago, whose suitability for these organs is decreasing.”Sensitive”, which are also among the most available today.

After a first installment raised in 2022, this second Series A installment will allow Advanced Life Solutions to finance its next stages of development and international deployment. The two family offices that entered into capital during the first phase (2022) are leading this new financing stage.

THM Capital Advisory supported Advanced Life Solutions throughout the operation as financial advisor (team: to be completed as soon as you give me the exact names on the THM side).

THM Capital Advisory supported the founders of Advanced Life Solutions as financial advisor, with a team composed of Thomas Mitard and Aurélien Prost, while McDermott Will & Emery (Henri Pieyre de Mandiargues) acted as legal advisor.

THM Capital Advisory assisted the shareholders of Alicante in the context of the sale of the company to the Ospi group, controlled by the Lauxera Capital Partners fund.

Alicante is a software publisher expert in medical coding and the valorization of health data using artificial intelligence, at the service of health institutions.

With Alicante, the Ospi group (ex-PSIH Group) is completing a second acquisition in the field of medical coding and the valorization of health data using AI, after the takeover of the company Collective Thinking in 2023.

This operation is part of Ospi's development strategy aimed at strengthening its offer in order to improve the efficiency of healthcare institutions and accelerate clinical research for the benefit of patients.

A pioneer company for 25 years, Alicante has developed expertise in AI centered on semantic analysis search engines dedicated to health institutions.

Since 2018, Alicante has been publishing a software suite that allows public and private health institutions to optimize, automate and control the quality of their PMSI coding (coding of medical procedures performed), presented as the main source of income for establishments paid by CNAM.

The merger with Alicante will allow the Ospi group to benefit from the hospital expertise of the Hauts-de-France publisher, by enriching the group's historical applications.

This transaction is the result of a process of backing up with a strategic partner led by THM Capital Advisory on behalf of Alicante shareholders (private shareholders and regional investment funds).

David Delerue, CEO and co-founder of Alicante, becomes Director of the Medical Coding Business Unit:

“Our customers will benefit from a unified, innovative offer and reinforced support thanks to a common technical DNA between the companies of the Ospi group.”

THM Capital Advisory supports WOMED in its €6 million Series A to launch Womed Leaf™ and accelerate its portfolio of intrauterine therapies.

WOMED announces a fundraising of 6 million euros in Series A, financed by private investors and the French fund IRDI, with THM Capital Advisory as the sole financial advisor for the operation.

WOMED is a Femtech startup that develops innovative, safe and effective treatments to help fight infertility and complex uterine pathologies.

The company was founded by the healthtech entrepreneur Gonzague Issenmann, Professor Xavier Garric, a specialist in biomedical polymers, and Dr. Stephanie Huberlant, a reproductive specialist, in order to commercialize an invention from the laboratory.”Polymers for Health and Biomaterials” from the University of Montpellier (France).

This proprietary technology forms the basis of a platform dedicated to intrauterine solutions, designed to directly target the uterine cavity, where the pathology is localized.

The first product, Womed Leaf™, is a medical device intended to treat and prevent uterine wall attachment after surgery (intrauterine adhesions), a complication that may be responsible for infertility and obstetric complications such as abnormal placentation.

Womed Leaf™ has obtained the CE mark in accordance with the new European regulations, and clinical trial effectiveness data is due to be presented in the first half of 2024.

Beyond Leaf™, WOMED is developing intrauterine drug delivery therapies for the treatment of fibroids, endometriosis and acute bleeding, which affect hundreds of millions of women around the world.

The purpose of Series A is to fund the commercial launch of Leaf™ and the continued development of this portfolio of proprietary intrauterine therapies.

THM Capital Advisory supported the founders of WOMED as financial advisor, with a team composed of Thomas Mitard, Juan Fernando Ramirez, Aurélien Prost and Paul Demorge, alongside Villechenon (Morgan Hunault-Berret, Quentin Dupont) as legal advisor.

Investors were advised on IP & legal aspects by LPA-CGR Avocats (Mathieu Selva, Stéphane Erard), as well as by White & Case (Alexandre Ippolito, Baptiste Ferraud) and Raion (Claire Feller).

THM Capital Advisory advised the shareholders of JBH Santé in connection with the sale of the company to the France Conventions group.

With this operation, France Conventions, organizer of leading exhibitions in contemporary art (Art Paris) and real estate (Sibca, Low Carbon Real Estate Show), decides to enter the health market by relying on a recognized platform for medical conferences and professional publishing.

JBH Santé organizes medical conferences mainly in ophthalmology, as well as rheumatology and gynecology, and publishes three journals in these same specialties.

The JROs (Ophthalmological Reflections Days), an annual ophthalmology conference of reference in France, constitute the main asset of the company, complemented by the organization of congresses and symposiums in regions on specific ophthalmology themes.

Taken over in 2021 by Emmanuelle Gorsse, a professional in the organization of exhibitions and conferences, accompanied by three active private shareholders, the company created more than 25 years ago by Dr. Jacques Halimi has received a new impetus.

Emmanuelle Gorsse says:

“We managed to perpetuate and improve the digital transformations undertaken during the health crisis while developing four new congresses on our specialties. We also improved the financial performance of JBH Santé by increasing advertising revenue from magazines and rationalizing conference organization costs. (...) We have every confidence in France Conventions to maintain this growth momentum.”

Julien Lecêtre, who owns and manages the France Conventions group with his sister Valentine Lecêtre, indicates:

“We want to build on the solid positions of JBH Santé in a resilient medical sector to create new conferences and consolidate the Company's successful start in consulting and scientific studies.”

THM Capital Advisory advised the shareholders of JBH Santé as financial advisor.

THM Capital Advisory advised Alicante on the sale of the CotOptim software to 123CS, a company specializing in the computer security of information systems and the provision of IT solutions for health professionals.

Since September 2023, 123CS — until now a subsidiary of the Verso Healthcare Group within MACSF — has been taken over by the founder of Verso Healthcare.

Alicante has been a pioneer company for 25 years in the development of expertise in artificial intelligence, focused on semantic analysis search engines and dedicated to health.

Since 2018, the publisher has been developing a software suite allowing public and private MCO and SMR health institutions to optimize, automate and perform quality control on their PMSI coding.

In this context, Alicante has applied its expertise by developing CotOptim, an AI software that lists the comprehensiveness of medical procedures performed and the quality of their coding in order to optimize the revenues of radiology practices.

Dedicated to private radiological practices and to the radiology departments of hospitals and clinics, CotOptim also aims to improve the quality control of billing, to reduce billing rejections and to limit the time spent on these tasks by medical and administrative teams.

This operation responds to a logic of strategic focus: Alicante has decided to sell CotOptim in order to focus on its core customers — MCO and SMR hospitals and clinics — while 123CS strengthens its range of products and services and intends to accelerate the commercial development of CotOptim among radiologists.

THM Capital Advisory advised Alicante as financial advisor (Thomas Mitard, Aurélien Prost), and Skills Avocats (Plamenka Kuna Renard) acted as legal advisor to the purchaser.

THM Capital Advisory was recently published in Challenges magazine. This article highlights our expertise in supporting entrepreneurs in the health sector with all their capital challenges, whether they are fundraising, acquisition or sale transactions.

It also looks at our specific positioning in the world of health, as well as on the complementarity of our team, composed of financial profiles and recognized experts in the pharmaceutical, medical and legal sectors.

Read the article on www.challenges.fr

THM Capital Advisory advised Thélème's shareholders in connection with the sale of the company to the EDL group.

This transaction is the first acquisition of EDL since its association with Abénex 18 months ago, and is part of a development strategy aimed at extending the group's offer to other specialties and regions, with the ambition of becoming a European leader in medical imaging.

Thélème is a publisher of software solutions dedicated in particular to the management of nuclear medicine facilities. Thanks to this acquisition, EDL significantly strengthens its positioning in software dedicated to nuclear medicine in France and has development prospects abroad.

Thélème's teams have significant know-how and around 25 years of experience, enriching the range of skills of the EDL group. Thélème is recognized for its technical expertise and the quality of its customer service, and the complementarity of customers should allow the two players to strengthen their respective positions.

The transaction also opens up new growth prospects for Thélème in the public sector in France and Belgium.

Alain Lopez and Frédéric Camboulives, respectively President and CEO of the EDL Group, declare:

“The acquisition of Thélème is an important step in order to strengthen our position in nuclear medicine in France and to enter new foreign markets. We are very happy to welcome Thélème's teams to EDL who will strengthen the Group's technological skills.”

Jérôme Vandermarcq, Partner at Abénex, states:

“This acquisition is fully integrated into EDL's development strategy built with its managers when we acquired a stake in 2021 (...) Other potential acquisitions currently under consideration are part of this consolidation process.”

THM Capital Advisory advised the sellers as financial advisor (Thomas Mitard, Aurélien Prost).

THM Capital Advisory is supporting Advanced Life Solutions in its €4.5M Series A to accelerate the development of Perla® in transplantation. Advanced Life Solutions (ALS) announces the completion of the first phase of its Series A, with the support of THM Capital Advisory.

ALS is developing Perla®, a new patented liquid for the preservation and protection of grafts, aimed at improving the functional recovery of transplanted organs and their lifespan.

Founded by Silvina Ramella, an internationally recognized scientist in organ transplantation and former director of one of the main European companies in the sector, ALS was created in order to market an innovative formulation developed and patented by the University of Barcelona.

Perla® was designed to respond to the evolution of transplants, by helping to better protect more fragile grafts, especially from older donors.

ALS also points out that the preservation fluids currently used in transplant services have existed for 20 to 35 years and are less and less adapted to this type of more “sensitive” organ.

After a €1.8 million seed round with private investors and the BPI, which made it possible to carry out preclinical trials as well as a first clinical safety trial, ALS concludes a €4.5 million Series A with two family holdings, Pharmanet and Cantrak.

The objective of this round is to finalize the obtaining of the CE mark and to obtain FDA approval in the United States.

Perla® is the first step in deploying a broad range of solutions, with two other projects under development to improve the protection of transplanted organs.

THM Capital Advisory supported the managers of Advanced Life Solutions as financial advisor, and McDermott Will & Emery (Henri Pieyre de Mandiargues, Louis Feuillée) acted as legal advisor.

THM Capital Advisory announces that it has advised the shareholders of the IMC radiological group in connection with the sale of the company to the SIMAGO group.

Located in Aisne, the IMC group operates 2 offices in Chauny and Fargniers, as well as 2 GIEs with local hospitals — one dedicated to scanners, the other to MRIs.

Approaching their sixties, IMC radiologists wanted to prepare for their retirement in the best conditions, faced with the difficulty of finding among young radiologists successors ready to take over the structure.

They called on THM Capital Advisory to assist them in identifying a purchaser and negotiating the terms of the transaction, by seeking advice specialized in sales, acquisitions and fundraising operations in the health sector.

The choice of IMC radiologists fell on SIMAGO, based on the trust established with the founders of the group, the ability to continue their activity under preserved working conditions, and the management by SIMAGO of operational management — schedules, recruitment of radiologists and substitutes.

The sellers were also able to reinvest in SIMAGO's capital at attractive conditions.

THM Capital Advisory advised the sellers as financial advisor (Thomas Mitard, Aurélien Prost), alongside MF2A (Jérôme Majbruch) as legal advisor.

The purchaser was supported by KPMG (Damien Moron) for financial due diligence, KPMG Avocats (David Lucas, Hamza M'Hamedi) for tax due diligence, and Cheysson Marchadier & Associés (François Marchadier, Elisabeth Dos Moron) for financial due diligence, KPMG Avocats (David Lucas, Hamza M'Hamedi) for tax due diligence, and Cheysson Marchadier & Associés (François Marchadier, Elisabeth Dos Santos, Marc Demazeau) as well as Ollyns (Cyrille Garnier, Eric Laugier) as legal advice.

THM Capital Advisory supports Cutting Edge in its fundraising to accelerate the development of its range of hydrophobic intraocular implants.

Cutting Edge announces a fund raising from a chemical group specialized in the production of polymers, its two founding directors Yves Brouquet and Jean-Pierre Boudet, as well as a private shareholder. THM Capital Advisory acted as financial advisor to the managers in connection with this transaction.

Founded in 2015 and based in Labège (31), Cutting Edge designs, produces and markets intraocular implants for the treatment of cataracts. The company has developed a complete range and obtained 9 CE markings, testifying to the maturity of its product portfolio.

Historically specialized in hydrophilic polymer implants, Cutting Edge is taking a new step forward by strengthening its equity to increase its production capacity for hydrophobic polymer implants, for which global demand is growing rapidly.

This fundraising should enable the company to accelerate its commercial development in France and abroad in around twenty countries, before continuing to extend its product range — through internal R&D developments or by acquisition — from 2023.

THM Capital Advisory advised the managers as financial advisor (Thomas Mitard), alongside Eleom Avocats (Pascal Roze) as legal advisor.

The investor was accompanied by Themis Conseils (Cindy Mantovani-Lefèvre) for the legal aspect.

THM Capital Advisory advised the purchasers of JBH Santé, a company specialized in the organization of medical conferences and the publication of professional journals in ophthalmology, rheumatology and gynecology.

The company's main asset consists of the JROs (Journées de Réflexions Ophtalmologiques), an annual ophthalmology conference of reference in France, complemented by the organization of congresses and symposiums in regions on specific ophthalmology topics.

Created 25 years ago by Jacques Halimi, a rheumatologist, JBH Santé has weathered the health crisis with resilience: after the forced cancellation of the JROs in March 2020, the company succeeded in a few months in transforming its historical face-to-face conferences into digital events, which proved to be very successful.

It is this ability to adapt that definitively convinced Emmanuelle Gorsse, a professional in the organization of fairs and congresses, to take over the company, accompanied by three private shareholders, including two trade fair specialists.

Jacques Halimi remains involved alongside the new shareholders to ensure a transfer under the best conditions.

THM Capital Advisory advised the acquirers as financial advisor (Thomas Mitard), alongside Volta (Gontran Souweine, François-Joseph Brix) as legal advisor and RBB (Jean-Baptiste Bonnefoux) for financial due diligence.

The seller was accompanied by Benjamin Marinho & Partners (Benjamin Marinho) for the financial part and by Jean-David Guedj et Associés (Jean-David Guedj) for the legal part.

THM Capital Advisory advised Bertrand Bisch, founder of e-Media, in connection with the sale of his company to the MedIn+ group, a pioneer and leader in teleradiology and telemedicine.

Founded 20 years ago in Illkirch-Graffenstaden, e-Media is a software publisher dedicated to medical imaging. The company has historically marketed PACS (archiving and image transfer) as well as systems for writing exams on CDs.

Over the past five years, e-Media has developed the Media BOX, a medical imaging data transfer solution that meets the needs of teleradiology, telemedicine, but also artificial intelligence companies and clinical trials. Its solutions are now deployed on 260 sites, 42% of which are hospitals, with the balance consisting of imaging centers.

By joining MedIn+, e-Media will benefit from strengthened resources to accelerate its development, while maintaining one of its main strengths: proximity to its customers. As part of the transaction, Daniel Kuentz, current CEO, takes over the operational role of Bertrand Bisch, who nevertheless remains involved in the group's project.

THM Capital Advisory advised the transferor as financial advisor (Thomas Mitard), alongside Eric Nonnenmacher as legal advisor.

The purchaser was accompanied by Lamartine (Raphaël Saulneron) for the legal aspects and by Repère Groupe (Julien Trelhu) for the financial due diligence.

THM Capital Advisory advised NEHS Digital in connection with the acquisition by MNH Group of all the capital of Medibase Systèmes and 51% of Vieviewer Entreprise, a company developing universal interfaces for visualizing medical data.

Created in 1997, Medibase Systèmes publishes Osoft®, a medical file management software for private health institutions and specialist doctors, used by nearly 3,500 private doctors and around fifty clinics. Medibase achieved a turnover of nearly €3 million in 2017.

At the beginning of 2017, the publisher created Vieviewer Enterprise, whose solution aggregates data from various hospital, medical and administrative software onto a single interface, in order to provide a global vision of the patient journey and HR data.

Vieviewer is already deployed in six hospital establishments, including the Metz-Thionville CHR, and benefits from an active commercial pipeline with support sites for GHT (regional hospital groups), with a turnover of €300K in 2017.

This double acquisition is part of MNH Group's strategy to create an integrated digital ecosystem at the service of health professionals, alongside other investments in Keldoc (online appointment booking), NGI (medical imaging) and Acetiam (telemedicine).

The merger with MNH Group will allow Medibase and Vieviewer to accelerate their development by benefiting from the group's resources and synergies, while maintaining their entrepreneurial autonomy.

THM Capital Advisory advised the NEHS group on the acquisition of Acetiam and NGI, two leading players in information systems and technological solutions dedicated to radiology.

Acetiam, created by the merger of Etiam and Accelis, provides radiology departments in hospitals and private practices with imaging archiving (PACS) and management (RIS) solutions.

The company has also established itself as a major player in telemedicine, by developing tools and infrastructure that allow institutions to mobilize their skills remotely and collaborate to offer the best care for each patient.

This acquisition was completed by that of NGI, leader in France in medical imaging solutions for private radiology practices. Like Acetiam, NGI develops ranges of PACS and RIS, and also ensures the distribution, installation and maintenance of radiological equipment.

Together, Acetiam and NGI allow NEHS to constitute a comprehensive service center for radiologists, covering both public institutions and liberal structures.

THM Capital Advisory advised the Scopus-Omnibadges group on the acquisition of ICTS, a distributor of cards, printers and associated accessories.

The Scopus-Omnibadges group is one of the French leaders in the identification and authentication of people by badge.

With this acquisition, Scopus is continuing to consolidate its market and strengthening its presence with major French accounts, and in particular major banks.

This operation is part of the development strategy deployed by Don-Pierre Pompéi, President of Scopus, since he took over the group in 2015 — combining organic growth, with solutions such as Scopus Online or Scopus Chantier (mobile identification), and external growth, and external growth, in order to cover all the problems of using digital identifiers in business: physical and logical access control, catering, food distribution, and analytical breakdown of expenses.

Patrick Fleuriot, owner and manager of ICTS, remains at the helm of the company and will make his customers benefit from the innovative offers of the Scopus Group.

THM Capital Advisory advised the purchaser as financial advisor (Thomas Mitard), alongside Cabinet Lamartine (Bintou Niang, Aude Marcheux) as legal advisor and ACA-Nexia (Fabrice Huglin) for accounting and tax audit.

The transferor was accompanied by Cabinet Fidorg (Damien Charrier, Guy Fleuriot).

THM Capital Advisory advised the NEHS group on the acquisition of Accelis by MNH Group, less than three months after acquiring a majority stake in the telemedicine operator Etiam.

This operation gives birth to Acetiam, a new entity merging the expertise of both companies.

Accelis is a publisher and distributor of radiological information systems (RIS), image archiving and visualization systems (PACS), and operator of regional telemedicine platforms in Hauts-de-France and New Aquitaine.

By combining its solutions with those of Etiam — operator of the platforms in Île-de-France and Rhône-Alpes — Acetiam now covers nearly 50% of the French population in telemedicine services.

The new entity is present in one health institution out of two nationwide, i.e. around 500 establishments, including all CHUs and regional cancer centers, representing more than 4,000 connected medical specialists and more than 25 million images teletransmitted each month.

Acetiam is positioned as a key player in medical cooperation within territorial hospital groups (GHT), by offering a progressive approach allowing communication between heterogeneous information systems.

This acquisition is part of MNH Group's external growth strategy, which has been in place since 2014, aimed at creating a comprehensive digital ecosystem at the service of healthcare professionals.

The new entity brings together 80 employees spread over five offices (Rennes, Nice, Nice, Bordeaux, Paris, Lille), including an R&D team of fifteen developers.

La Meringaie announces the closing of a €825K fundraiser from private investors, with the support of THM Capital Advisory as financial advisor for investor relations.

Created in 2015 and winner of the Réseau Entrepreneurs Paris 2016, La Meringaie is a high-end Parisian pastry concept centered on meringue.

The company was founded by five enthusiasts from the biggest houses: Marie Stoclet-Bardon (Fauchon, La Maison du Chocolat), Charlotte Sindou-Faurie (chef trained at Ferrandi), Gilles Marchal (Le Bristol, La Maison du Chocolat), Marie Stoclet-Bardon (La Maison du Chocolat), Oliver Designets (La Maison du Chocolat), and Benoît Bardon (Veolia).

La Meringaie offers an offer centered on Pavlova®, a meringue that is crunchy on the outside and soft on the inside, accompanied by fragrant whipped cream and fresh seasonal fruit, available in its shop-shop at 21 rue de Lévis (Paris 17th) as well as on its online site.

The funds raised will allow La Meringaie to develop its presence in Paris with the opening of new points of sale, including a new Left Bank store near Le Bon Marché scheduled for September.

THM Capital Advisory supported La Meringaie as financial advisor, alongside Joffe & Associés as legal advisor.

Thomas Mitard, founder of THM Capital Advisory, discusses the firm's philosophy and approach alongside two managers he supported: Christophe Montague, founder of 5M Venture, and Don-Pierre Pompei, CEO of Scopus Omnibadge.

Through their testimonies, they share their experience of a sale or fund raising operation advised by THM Capital Advisory, and what it actually means to support an advisor specialized in this type of transaction.

‍